Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

克拉斯 医学 内科学 危险系数 肿瘤科 肺癌 突变 子群分析 癌症 比例危险模型 胃肠病学 置信区间 结直肠癌 生物 生物化学 基因
作者
Si‐Yang Liu,Hao Sun,Jiaying Zhou,Guang‐Ling Jie,Zhi Xie,Yang Shao,Xian Zhang,Junyi Ye,Chunxiang Chen,Xu‐Chao Zhang,Qing Zhou,Jin‐Ji Yang,Yi−Long Wu
出处
期刊:Biomarker research [BioMed Central]
卷期号:8 (1) 被引量:59
标识
DOI:10.1186/s40364-020-00199-z
摘要

The KRAS mutation is the second most common genetic variant in Chinese non-small cell lung cancer (NSCLC) patients. At the 2019th World Conference of Lung Cancer, the KRAS G12C-specific inhibitor AMG510 showed promising results in the phase I clinical trial. However, the frequency, clinical characteristics, and prognostic significance of the KRAS G12C mutation in Chinese NSCLC patients are rarely reported.Next-generation sequencing was used to confirm the KRAS mutation status in 40,804 NSCLC patients from multiple centers (mCohort). Survival data were collected retrospectively from 1456 patients at one of the centers, the Guangdong Lung Cancer Institute (iCohort).In the mCohort, 3998 patients (9.8%) were confirmed to harbor a KRAS mutation, of whom 1179 (29.5%) had the G12C subtype. In the iCohort, 130 NSCLC patients (8.9%) had a KRAS mutation and 42 (32.3%) had the G12C subtype. The G12C subgroup included more male patients (85.2% vs 67.4%, P < 0.0001) and more smokers (76.2% vs 53.4%, P = 0.02) than did the non-G12C subgroup. Both the KRAS mutation group and KRAS G12C mutation subgroup were associated with a shorter median overall survival (OS) than wildtype tumors (15.1 vs 26.7 months, hazard ratio [HR] KRAS = 1.50, P = 0.002; 18.3 vs 26.7 months, HR G12C = 1.66, P = 0.007). In Cox regression analysis, smoking (HR = 1.39, P = 0.05) and stage IV disease (HR = 2.72, P < 0.001) remained as independent predictors of shorter OS. Both the KRAS mutation (HR = 1.30, P = 0.07) and KRAS G12C mutation (HR = 1.47, P = 0.07) reached borderline significance.In the largest sample used thus for, our study found that approximately 10% of Chinese NSCLC patients had KRAS mutations. Of these, nearly 30% harbored the KRAS G12C mutation subtype, which was most common in male smokers. The KRAS G12C mutation is a biomarker of poor prognosis in Chinese NSCLC patients, which could potentially be improved by G12C-specific inhibitors in the future.(296 words).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
优美煎蛋发布了新的文献求助10
刚刚
iuwallace发布了新的文献求助10
1秒前
milion完成签到,获得积分10
1秒前
1秒前
1秒前
YitingW发布了新的文献求助10
1秒前
1秒前
研友_nVj3yn发布了新的文献求助10
1秒前
斯文败类的应助被chuhan采纳,获得10
1秒前
gela发布了新的文献求助10
2秒前
bkagyin的应助被我爱玩原神采纳,获得10
2秒前
汉堡包的应助被Ma采纳,获得10
2秒前
Ava的应助被wu采纳,获得10
2秒前
李元发布了新的文献求助10
2秒前
zzl发布了新的文献求助10
3秒前
Maestro_S的应助被职克琪采纳,获得10
3秒前
隐形曼青的应助被职克琪采纳,获得10
3秒前
3秒前
zxy发布了新的文献求助10
3秒前
甜美的兔子完成签到,获得积分10
4秒前
4秒前
accepted完成签到,获得积分10
4秒前
传奇3的应助被愤怒的水壶采纳,获得10
4秒前
SciGPT的应助被lawliet采纳,获得10
4秒前
小零完成签到,获得积分10
4秒前
Maestro_S的应助被h11采纳,获得10
4秒前
jhlllllll发布了新的文献求助10
4秒前
董文强发布了新的文献求助10
5秒前
5秒前
5秒前
清风明月发布了新的文献求助10
5秒前
迷了路的猫完成签到,获得积分10
6秒前
6秒前
jonghuang发布了新的文献求助10
9秒前
赘婿的应助被window1000采纳,获得10
9秒前
贤君发布了新的文献求助10
9秒前
10秒前
10秒前
cz完成签到,获得积分10
11秒前
闪闪的灵发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8164445
求助须知:如何正确求助?哪些是违规求助? 9558283
关于积分的说明 21744871
捐赠科研通 7754979
什么是DOI,文献DOI怎么找? 3428582
关于科研通互助平台的介绍 2553119
邀请新用户注册赠送积分活动 2473142